Evaluation of the prevalence of asthma and chronic obstructive pulmonary disease among opium users, and cigarette smokers and comparison with normal population in Kharameh: a cross-sectional study
Background Recent studies have suggested that opium use may increase mortality from pulmonary diseases. However, there are limited comprehensive studies regarding the prevalence of Asthma and Chronic Obstructive Pulmonary Disease (COPD) among tobacco and opium users has been published. We aimed to d...
Saved in:
Published in | BMC pulmonary medicine Vol. 23; no. 1; pp. 1 - 8 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
01.11.2023
BioMed Central Ltd BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1471-2466 1471-2466 |
DOI | 10.1186/s12890-023-02734-8 |
Cover
Abstract | Background
Recent studies have suggested that opium use may increase mortality from pulmonary diseases. However, there are limited comprehensive studies regarding the prevalence of Asthma and Chronic Obstructive Pulmonary Disease (COPD) among tobacco and opium users has been published. We aimed to determine the prevalence of respiratory disease among tobacco and opium users.
Methods
This cross-sectional study of tobacco and opium users and matched controls was conducted in the Kharameh Cohort, Fars, Iran. The prevalence of COPD and asthma, along with the participants demographical and spirometry data were examined.
Results
The average age of participants was 57 ± 8 years. Never smokers had a significant higher BMI (26.6 vs. 24.8), FEV1 (91% vs. 82%) and FVC (96% vs. 88%) values compared to participants with a positive smoking status. There was a statistical difference in the prevalence of COPD, asthma, and asthma COPD overlap (ACO) based on the participants smoking status, with the highest prevalence among opium and cigarette smokers, followed by opium users alone. Based on multivariate analysis, higher age, lower BMI, lower education than under diploma, cigarette smoking and opium use were significantly correlated with higher COPD prevalence; while lower age, cigarette smoking and opium use were significantly correlated with higher asthma prevalence. Illiterate participants had a significantly higher prevalence of COPD (23.6%), asthma (22%), and ACO (7.9%) among the educational groups. Regarding the prevalence of asthma, the higher socio-economic group had the lowest prevalence.
Conclusions
Opium and tobacco users had a significantly higher prevalence of respiratory diseases, along with lower lung function tests based on spirometry evaluation. |
---|---|
AbstractList | Recent studies have suggested that opium use may increase mortality from pulmonary diseases. However, there are limited comprehensive studies regarding the prevalence of Asthma and Chronic Obstructive Pulmonary Disease (COPD) among tobacco and opium users has been published. We aimed to determine the prevalence of respiratory disease among tobacco and opium users. This cross-sectional study of tobacco and opium users and matched controls was conducted in the Kharameh Cohort, Fars, Iran. The prevalence of COPD and asthma, along with the participants demographical and spirometry data were examined. The average age of participants was 57 [+ or -] 8 years. Never smokers had a significant higher BMI (26.6 vs. 24.8), FEV1 (91% vs. 82%) and FVC (96% vs. 88%) values compared to participants with a positive smoking status. There was a statistical difference in the prevalence of COPD, asthma, and asthma COPD overlap (ACO) based on the participants smoking status, with the highest prevalence among opium and cigarette smokers, followed by opium users alone. Based on multivariate analysis, higher age, lower BMI, lower education than under diploma, cigarette smoking and opium use were significantly correlated with higher COPD prevalence; while lower age, cigarette smoking and opium use were significantly correlated with higher asthma prevalence. Illiterate participants had a significantly higher prevalence of COPD (23.6%), asthma (22%), and ACO (7.9%) among the educational groups. Regarding the prevalence of asthma, the higher socio-economic group had the lowest prevalence. Opium and tobacco users had a significantly higher prevalence of respiratory diseases, along with lower lung function tests based on spirometry evaluation. Background Recent studies have suggested that opium use may increase mortality from pulmonary diseases. However, there are limited comprehensive studies regarding the prevalence of Asthma and Chronic Obstructive Pulmonary Disease (COPD) among tobacco and opium users has been published. We aimed to determine the prevalence of respiratory disease among tobacco and opium users. Methods This cross-sectional study of tobacco and opium users and matched controls was conducted in the Kharameh Cohort, Fars, Iran. The prevalence of COPD and asthma, along with the participants demographical and spirometry data were examined. Results The average age of participants was 57 [+ or -] 8 years. Never smokers had a significant higher BMI (26.6 vs. 24.8), FEV1 (91% vs. 82%) and FVC (96% vs. 88%) values compared to participants with a positive smoking status. There was a statistical difference in the prevalence of COPD, asthma, and asthma COPD overlap (ACO) based on the participants smoking status, with the highest prevalence among opium and cigarette smokers, followed by opium users alone. Based on multivariate analysis, higher age, lower BMI, lower education than under diploma, cigarette smoking and opium use were significantly correlated with higher COPD prevalence; while lower age, cigarette smoking and opium use were significantly correlated with higher asthma prevalence. Illiterate participants had a significantly higher prevalence of COPD (23.6%), asthma (22%), and ACO (7.9%) among the educational groups. Regarding the prevalence of asthma, the higher socio-economic group had the lowest prevalence. Conclusions Opium and tobacco users had a significantly higher prevalence of respiratory diseases, along with lower lung function tests based on spirometry evaluation. Keywords: Cohort, COPD, Asthma, Prevalence, Iran Recent studies have suggested that opium use may increase mortality from pulmonary diseases. However, there are limited comprehensive studies regarding the prevalence of Asthma and Chronic Obstructive Pulmonary Disease (COPD) among tobacco and opium users has been published. We aimed to determine the prevalence of respiratory disease among tobacco and opium users.BACKGROUNDRecent studies have suggested that opium use may increase mortality from pulmonary diseases. However, there are limited comprehensive studies regarding the prevalence of Asthma and Chronic Obstructive Pulmonary Disease (COPD) among tobacco and opium users has been published. We aimed to determine the prevalence of respiratory disease among tobacco and opium users.This cross-sectional study of tobacco and opium users and matched controls was conducted in the Kharameh Cohort, Fars, Iran. The prevalence of COPD and asthma, along with the participants demographical and spirometry data were examined.METHODSThis cross-sectional study of tobacco and opium users and matched controls was conducted in the Kharameh Cohort, Fars, Iran. The prevalence of COPD and asthma, along with the participants demographical and spirometry data were examined.The average age of participants was 57 ± 8 years. Never smokers had a significant higher BMI (26.6 vs. 24.8), FEV1 (91% vs. 82%) and FVC (96% vs. 88%) values compared to participants with a positive smoking status. There was a statistical difference in the prevalence of COPD, asthma, and asthma COPD overlap (ACO) based on the participants smoking status, with the highest prevalence among opium and cigarette smokers, followed by opium users alone. Based on multivariate analysis, higher age, lower BMI, lower education than under diploma, cigarette smoking and opium use were significantly correlated with higher COPD prevalence; while lower age, cigarette smoking and opium use were significantly correlated with higher asthma prevalence. Illiterate participants had a significantly higher prevalence of COPD (23.6%), asthma (22%), and ACO (7.9%) among the educational groups. Regarding the prevalence of asthma, the higher socio-economic group had the lowest prevalence.RESULTSThe average age of participants was 57 ± 8 years. Never smokers had a significant higher BMI (26.6 vs. 24.8), FEV1 (91% vs. 82%) and FVC (96% vs. 88%) values compared to participants with a positive smoking status. There was a statistical difference in the prevalence of COPD, asthma, and asthma COPD overlap (ACO) based on the participants smoking status, with the highest prevalence among opium and cigarette smokers, followed by opium users alone. Based on multivariate analysis, higher age, lower BMI, lower education than under diploma, cigarette smoking and opium use were significantly correlated with higher COPD prevalence; while lower age, cigarette smoking and opium use were significantly correlated with higher asthma prevalence. Illiterate participants had a significantly higher prevalence of COPD (23.6%), asthma (22%), and ACO (7.9%) among the educational groups. Regarding the prevalence of asthma, the higher socio-economic group had the lowest prevalence.Opium and tobacco users had a significantly higher prevalence of respiratory diseases, along with lower lung function tests based on spirometry evaluation.CONCLUSIONSOpium and tobacco users had a significantly higher prevalence of respiratory diseases, along with lower lung function tests based on spirometry evaluation. Background Recent studies have suggested that opium use may increase mortality from pulmonary diseases. However, there are limited comprehensive studies regarding the prevalence of Asthma and Chronic Obstructive Pulmonary Disease (COPD) among tobacco and opium users has been published. We aimed to determine the prevalence of respiratory disease among tobacco and opium users. Methods This cross-sectional study of tobacco and opium users and matched controls was conducted in the Kharameh Cohort, Fars, Iran. The prevalence of COPD and asthma, along with the participants demographical and spirometry data were examined. Results The average age of participants was 57 ± 8 years. Never smokers had a significant higher BMI (26.6 vs. 24.8), FEV1 (91% vs. 82%) and FVC (96% vs. 88%) values compared to participants with a positive smoking status. There was a statistical difference in the prevalence of COPD, asthma, and asthma COPD overlap (ACO) based on the participants smoking status, with the highest prevalence among opium and cigarette smokers, followed by opium users alone. Based on multivariate analysis, higher age, lower BMI, lower education than under diploma, cigarette smoking and opium use were significantly correlated with higher COPD prevalence; while lower age, cigarette smoking and opium use were significantly correlated with higher asthma prevalence. Illiterate participants had a significantly higher prevalence of COPD (23.6%), asthma (22%), and ACO (7.9%) among the educational groups. Regarding the prevalence of asthma, the higher socio-economic group had the lowest prevalence. Conclusions Opium and tobacco users had a significantly higher prevalence of respiratory diseases, along with lower lung function tests based on spirometry evaluation. Abstract Background Recent studies have suggested that opium use may increase mortality from pulmonary diseases. However, there are limited comprehensive studies regarding the prevalence of Asthma and Chronic Obstructive Pulmonary Disease (COPD) among tobacco and opium users has been published. We aimed to determine the prevalence of respiratory disease among tobacco and opium users. Methods This cross-sectional study of tobacco and opium users and matched controls was conducted in the Kharameh Cohort, Fars, Iran. The prevalence of COPD and asthma, along with the participants demographical and spirometry data were examined. Results The average age of participants was 57 ± 8 years. Never smokers had a significant higher BMI (26.6 vs. 24.8), FEV1 (91% vs. 82%) and FVC (96% vs. 88%) values compared to participants with a positive smoking status. There was a statistical difference in the prevalence of COPD, asthma, and asthma COPD overlap (ACO) based on the participants smoking status, with the highest prevalence among opium and cigarette smokers, followed by opium users alone. Based on multivariate analysis, higher age, lower BMI, lower education than under diploma, cigarette smoking and opium use were significantly correlated with higher COPD prevalence; while lower age, cigarette smoking and opium use were significantly correlated with higher asthma prevalence. Illiterate participants had a significantly higher prevalence of COPD (23.6%), asthma (22%), and ACO (7.9%) among the educational groups. Regarding the prevalence of asthma, the higher socio-economic group had the lowest prevalence. Conclusions Opium and tobacco users had a significantly higher prevalence of respiratory diseases, along with lower lung function tests based on spirometry evaluation. BackgroundRecent studies have suggested that opium use may increase mortality from pulmonary diseases. However, there are limited comprehensive studies regarding the prevalence of Asthma and Chronic Obstructive Pulmonary Disease (COPD) among tobacco and opium users has been published. We aimed to determine the prevalence of respiratory disease among tobacco and opium users.MethodsThis cross-sectional study of tobacco and opium users and matched controls was conducted in the Kharameh Cohort, Fars, Iran. The prevalence of COPD and asthma, along with the participants demographical and spirometry data were examined.ResultsThe average age of participants was 57 ± 8 years. Never smokers had a significant higher BMI (26.6 vs. 24.8), FEV1 (91% vs. 82%) and FVC (96% vs. 88%) values compared to participants with a positive smoking status. There was a statistical difference in the prevalence of COPD, asthma, and asthma COPD overlap (ACO) based on the participants smoking status, with the highest prevalence among opium and cigarette smokers, followed by opium users alone. Based on multivariate analysis, higher age, lower BMI, lower education than under diploma, cigarette smoking and opium use were significantly correlated with higher COPD prevalence; while lower age, cigarette smoking and opium use were significantly correlated with higher asthma prevalence. Illiterate participants had a significantly higher prevalence of COPD (23.6%), asthma (22%), and ACO (7.9%) among the educational groups. Regarding the prevalence of asthma, the higher socio-economic group had the lowest prevalence.ConclusionsOpium and tobacco users had a significantly higher prevalence of respiratory diseases, along with lower lung function tests based on spirometry evaluation. |
ArticleNumber | 419 |
Audience | Academic |
Author | Rezaianzadeh, Abbas Raeisy, Laleh Masoompour, Seyed Masoom |
Author_xml | – sequence: 1 givenname: Laleh surname: Raeisy fullname: Raeisy, Laleh organization: Student Research committee of medical school, Shiraz University of Medical Sciences – sequence: 2 givenname: Seyed Masoom surname: Masoompour fullname: Masoompour, Seyed Masoom email: masoomm@sums.ac.ir organization: Non-Communicable Diseases Research Center, Shiraz University of Medical Sciences – sequence: 3 givenname: Abbas surname: Rezaianzadeh fullname: Rezaianzadeh, Abbas organization: Colorectal Research Center, Shiraz University of Medical Sciences |
BookMark | eNp9UsFu1DAUjFCRaAs_wMkSFw6k2LHjJFxQVRWoqMQFztZb-2XjJbEX22nV_-PD8G6KylaoiqI445mx33tzUhw577AoXjN6xlgr30dWtR0tacXz23BRts-KYyYaVlZCyqN_1i-Kkxg3lLKmrflx8fvyBsYZkvWO-J6kAck2YMbQadwhENMwAQFniB6Cd1YTv4opzDrZm0yex8k7CHfE2IgQkUD-XxO_tfNE5oghvlvEdg0BU0ISJ_8zwwvqpy0EG_PptzYNxPkwwUi2Pvsul7KOfB0gwITDBwJEBx9jGVHvNjMzptncvSye9zBGfHX_PS1-fLr8fvGlvP72-eri_LrUdVunUve00b0xhmsuBK8MQ62rhrVcY4dUU0oFyLpDMLIXvAfZNFJA7lOLDa-RnxZXi6_xsFHbYKdcuPJg1R7wYa0gJKtHVGzVihXQjmreCOxNt0JptJCGS6Bs1Wevj4vXdl5NaDS6FGA8MD3ccXZQa3-jGJWsq_KlT4u39w7B_5oxJjXZqHEcwaGfo6ratq5FDobI1DePqBs_h9y_HaujVDaMswfWOo9fWdf7fLDemarzpmFMNjWXmXX2H1Z-DE5W51j2NuMHgnYR7GcXsFfapv1ws9COuSC1y7BaMqxyhtU-w2pXYvVI-rc_T4r4IoqZ7NYYHop9QvUHGJ8LYw |
CitedBy_id | crossref_primary_10_1002_cnr2_70108 crossref_primary_10_1371_journal_pone_0310842 |
Cites_doi | 10.34172/aim.2020.17 10.1111/crj.13470 10.1155/2001/572825 10.1016/S2213-2600(14)70008-6 10.1093/aje/kwx314 10.1016/S0335-7457(03)00111-4 10.1136/thorax.58.4.322 10.1136/thx.26.5.555 10.1016/S0376-8716(02)00193-X 10.1136/bmj.38142.554479.AE 10.1016/j.cdip.2004.04.009 10.1016/S0012-3692(15)52588-9 10.1197/j.aem.2006.07.034 10.1001/archinte.167.3.221 10.1155/2007/830570 10.1136/bmj.e2502 10.1111/crj.12780 10.1038/s41533-019-0159-1 10.1136/bmjopen-2016-012823 10.1136/thx.2006.077081 10.1056/NEJM199810223391703 10.1097/00063198-200103000-00001 10.4104/pcrj.2012.00069 10.1186/s12889-018-6343-3 10.3109/15412555.2015.1082999 10.1016/j.jaci.2006.09.006 10.3109/02770909909075409 10.1046/j.1440-1843.2002.00399.x |
ContentType | Journal Article |
Copyright | The Author(s) 2023 COPYRIGHT 2023 BioMed Central Ltd. 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2023. The Author(s). |
Copyright_xml | – notice: The Author(s) 2023 – notice: COPYRIGHT 2023 BioMed Central Ltd. – notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2023. The Author(s). |
DBID | C6C AAYXX CITATION 3V. 7TO 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM DOA |
DOI | 10.1186/s12890-023-02734-8 |
DatabaseName | Springer Nature OA Free Journals CrossRef ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Database Suite (ProQuest) ProQuest One Community College ProQuest Central Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-2466 |
EndPage | 8 |
ExternalDocumentID | oai_doaj_org_article_1b84ba090c374efd9be6dc46d36a01bf PMC10619218 A771167536 10_1186_s12890_023_02734_8 |
GeographicLocations | Iran |
GeographicLocations_xml | – name: Iran |
GroupedDBID | --- 0R~ 23N 2WC 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABUWG ACGFO ACGFS ACIHN ACPRK ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EMB EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 UKHRP W2D WOQ WOW XSB AAYXX ALIPV CITATION PMFND 3V. 7TO 7XB 8FK AZQEC DWQXO H94 K9. PKEHL PQEST PQUKI 7X8 5PM |
ID | FETCH-LOGICAL-c585t-cf07cfddd3c34432d1ecc27183ce9e0c0004a659ead6f43fa67764a8538e735e3 |
IEDL.DBID | M48 |
ISSN | 1471-2466 |
IngestDate | Wed Aug 27 01:24:29 EDT 2025 Thu Aug 21 18:36:40 EDT 2025 Fri Sep 05 08:32:39 EDT 2025 Fri Jul 25 20:56:22 EDT 2025 Tue Jun 17 22:28:09 EDT 2025 Tue Jun 10 21:22:53 EDT 2025 Thu Apr 24 23:02:16 EDT 2025 Tue Jul 01 02:40:34 EDT 2025 Sat Sep 06 07:21:56 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Prevalence Cohort Iran COPD Asthma |
Language | English |
License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c585t-cf07cfddd3c34432d1ecc27183ce9e0c0004a659ead6f43fa67764a8538e735e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/2890067131?pq-origsite=%requestingapplication% |
PQID | 2890067131 |
PQPubID | 44785 |
PageCount | 8 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_1b84ba090c374efd9be6dc46d36a01bf pubmedcentral_primary_oai_pubmedcentral_nih_gov_10619218 proquest_miscellaneous_2885541284 proquest_journals_2890067131 gale_infotracmisc_A771167536 gale_infotracacademiconefile_A771167536 crossref_citationtrail_10_1186_s12890_023_02734_8 crossref_primary_10_1186_s12890_023_02734_8 springer_journals_10_1186_s12890_023_02734_8 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-11-01 |
PublicationDateYYYYMMDD | 2023-11-01 |
PublicationDate_xml | – month: 11 year: 2023 text: 2023-11-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London |
PublicationTitle | BMC pulmonary medicine |
PublicationTitleAbbrev | BMC Pulm Med |
PublicationYear | 2023 |
Publisher | BioMed Central BioMed Central Ltd BMC |
Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
References | MA Fallahzadeh (2734_CR29) 2017; 20 DE O’donnell (2734_CR5) 2007; 14 AK Karyani (2734_CR24) 2019; 19 H Mahdaviazad (2734_CR6) 2022; 16 JB Weitzman (2734_CR33) 1998; 122 A Iqbal (2734_CR19) 2002; 7 P Tirimanna (2734_CR23) 1996; 46 2734_CR8 N Anthonisen (2734_CR22) 2001; 8 M Buster (2734_CR39) 2002; 68 RC Jones (2734_CR42) 2014; 2 H Mahdaviazad (2734_CR11) 2020; 61 2734_CR20 H Poustchi (2734_CR25) 2018; 187 A Korsten (2734_CR21) 2003; 43 2734_CR28 2734_CR26 S Mehta (2734_CR27) 2020; 30 R Doll (2734_CR7) 2004; 328 K Agin (2734_CR12) 2014; 4 J Da Costa (2734_CR15) 1971; 26 DP Tashkin (2734_CR35) 2001; 7 SM Masoompour (2734_CR10) 2018; 12 S-C Yang (2734_CR17) 2010; 33 CA Mitchell (2734_CR41) 2016; 6 J Tomashefski Jr (2734_CR36) 2004; 10 M Heydari (2734_CR13) 2013; 11 N Lewis-Burke (2734_CR40) 2016; 13 M Daneshpajouh (2734_CR14) 1976; 32 JM Tetrault (2734_CR34) 2007; 167 F Palmer (2734_CR37) 2012; 21 K McCoy (2734_CR2) 2006; 118 CL Tsai (2734_CR3) 2007; 14 2734_CR31 J Vonk (2734_CR16) 2003; 58 2734_CR32 M Levine (2734_CR38) 2005; 128 P Lange (2734_CR1) 1998; 339 MD Althuis (2734_CR4) 1999; 36 DM Mannino (2734_CR9) 2002; 47 S Aldington (2734_CR43) 2007; 62 2734_CR18 A Adib (2734_CR30) 2020; 23 |
References_xml | – volume: 20 start-page: 0 issue: 4 year: 2017 ident: 2734_CR29 publication-title: Arch Iran Med – volume: 23 start-page: 289 issue: 5 year: 2020 ident: 2734_CR30 publication-title: Arch Iran Med doi: 10.34172/aim.2020.17 – volume: 16 start-page: 208 issue: 3 year: 2022 ident: 2734_CR6 publication-title: Clin Respir J doi: 10.1111/crj.13470 – volume: 8 start-page: 421 issue: 6 year: 2001 ident: 2734_CR22 publication-title: Can Respir J doi: 10.1155/2001/572825 – volume: 2 start-page: 267 issue: 4 year: 2014 ident: 2734_CR42 publication-title: The Lancet Respiratory Medicine doi: 10.1016/S2213-2600(14)70008-6 – volume: 33 start-page: 515 year: 2010 ident: 2734_CR17 publication-title: Chang Gung Med J – ident: 2734_CR32 – volume: 187 start-page: 647 issue: 4 year: 2018 ident: 2734_CR25 publication-title: Am J Epidemiol doi: 10.1093/aje/kwx314 – volume: 46 start-page: 277 issue: 406 year: 1996 ident: 2734_CR23 publication-title: Br J Gen Pract – volume: 43 start-page: 246 issue: 4 year: 2003 ident: 2734_CR21 publication-title: Revue française D’allergologie et d’immunologie Clinique doi: 10.1016/S0335-7457(03)00111-4 – volume: 58 start-page: 322 issue: 4 year: 2003 ident: 2734_CR16 publication-title: Thorax doi: 10.1136/thorax.58.4.322 – volume: 26 start-page: 555 issue: 5 year: 1971 ident: 2734_CR15 publication-title: Thorax doi: 10.1136/thx.26.5.555 – volume: 68 start-page: 221 issue: 2 year: 2002 ident: 2734_CR39 publication-title: Drug Alcohol Depend doi: 10.1016/S0376-8716(02)00193-X – volume: 328 start-page: 1519 issue: 7455 year: 2004 ident: 2734_CR7 publication-title: BMJ doi: 10.1136/bmj.38142.554479.AE – volume: 10 start-page: 413 issue: 5 year: 2004 ident: 2734_CR36 publication-title: Curr Diagn Pathol doi: 10.1016/j.cdip.2004.04.009 – volume: 128 start-page: 1951 issue: 4 year: 2005 ident: 2734_CR38 publication-title: Chest doi: 10.1016/S0012-3692(15)52588-9 – volume: 14 start-page: 6 issue: 1 year: 2007 ident: 2734_CR3 publication-title: Acad Emerg Med doi: 10.1197/j.aem.2006.07.034 – volume: 167 start-page: 221 issue: 3 year: 2007 ident: 2734_CR34 publication-title: Arch Intern Med doi: 10.1001/archinte.167.3.221 – volume: 32 start-page: 127 issue: 3 year: 1976 ident: 2734_CR14 publication-title: Le Poumon et le Coeur – volume: 14 start-page: 5B issue: Suppl B year: 2007 ident: 2734_CR5 publication-title: Can Respir J doi: 10.1155/2007/830570 – ident: 2734_CR8 – ident: 2734_CR18 doi: 10.1136/bmj.e2502 – volume: 4 start-page: 83 issue: 3 year: 2014 ident: 2734_CR12 publication-title: Int J Med Toxicol Forensic Med – volume: 12 start-page: 2110 issue: 6 year: 2018 ident: 2734_CR10 publication-title: Clin Respir J doi: 10.1111/crj.12780 – volume: 30 start-page: 1 issue: 1 year: 2020 ident: 2734_CR27 publication-title: NPJ Prim care Respiratory Med doi: 10.1038/s41533-019-0159-1 – volume: 6 start-page: e012823 issue: 10 year: 2016 ident: 2734_CR41 publication-title: BMJ open doi: 10.1136/bmjopen-2016-012823 – volume: 62 start-page: 1058 issue: 12 year: 2007 ident: 2734_CR43 publication-title: Thorax doi: 10.1136/thx.2006.077081 – volume: 339 start-page: 1194 issue: 17 year: 1998 ident: 2734_CR1 publication-title: N Engl J Med doi: 10.1056/NEJM199810223391703 – ident: 2734_CR31 – volume: 7 start-page: 43 issue: 2 year: 2001 ident: 2734_CR35 publication-title: Curr Opin Pulm Med doi: 10.1097/00063198-200103000-00001 – volume: 21 start-page: 377 issue: 4 year: 2012 ident: 2734_CR37 publication-title: Prim Care Respiratory J doi: 10.4104/pcrj.2012.00069 – volume: 47 start-page: 1184 issue: 10 year: 2002 ident: 2734_CR9 publication-title: Respir Care – volume: 61 start-page: E578 issue: 4 year: 2020 ident: 2734_CR11 publication-title: J Prev Med Hyg – ident: 2734_CR26 – volume: 19 start-page: 1 issue: 1 year: 2019 ident: 2734_CR24 publication-title: BMC Public Health doi: 10.1186/s12889-018-6343-3 – volume: 13 start-page: 333 issue: 3 year: 2016 ident: 2734_CR40 publication-title: Copd doi: 10.3109/15412555.2015.1082999 – volume: 118 start-page: 1226 issue: 6 year: 2006 ident: 2734_CR2 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2006.09.006 – volume: 36 start-page: 257 issue: 3 year: 1999 ident: 2734_CR4 publication-title: J Asthma doi: 10.3109/02770909909075409 – ident: 2734_CR20 – volume: 11 start-page: 101 issue: 1 year: 2013 ident: 2734_CR13 publication-title: Acta medico-historica Adriatica: AMHA – ident: 2734_CR28 – volume: 7 start-page: 233 issue: 3 year: 2002 ident: 2734_CR19 publication-title: Respirology doi: 10.1046/j.1440-1843.2002.00399.x – volume: 122 start-page: 691 issue: 8 year: 1998 ident: 2734_CR33 publication-title: Arch Pathol Lab Med |
SSID | ssj0017853 |
Score | 2.3465405 |
Snippet | Background
Recent studies have suggested that opium use may increase mortality from pulmonary diseases. However, there are limited comprehensive studies... Background Recent studies have suggested that opium use may increase mortality from pulmonary diseases. However, there are limited comprehensive studies... Recent studies have suggested that opium use may increase mortality from pulmonary diseases. However, there are limited comprehensive studies regarding the... BackgroundRecent studies have suggested that opium use may increase mortality from pulmonary diseases. However, there are limited comprehensive studies... Abstract Background Recent studies have suggested that opium use may increase mortality from pulmonary diseases. However, there are limited comprehensive... |
SourceID | doaj pubmedcentral proquest gale crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 1 |
SubjectTerms | Age Airway management Analysis Asthma Care and treatment Chronic obstructive pulmonary disease Cigarette smoking Cigarettes Cohort Cohort analysis COPD Critical Care Medicine Cross-sectional studies Data analysis Diagnosis Drug abuse Drug addicts Epidemiology Health aspects Intensive Internal Medicine Iran Lung diseases Lung diseases, Obstructive Medicine Medicine & Public Health Mortality Multivariate analysis Narcotics Obstructive lung disease Pneumology/Respiratory System Population Prevalence Primary care Pulmonary function tests Pulmonology Respiratory diseases Respiratory function Risk factors Smoking Smoking cessation Social aspects Sociodemographics Spirometry Tobacco Variables |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4ikCBRkJiQO1mqwdJ-FWUKsKVE5U6s3yU7tiN1k1u0j8P34YM44TCBVw4WqPEz--scce-xtCXi1snjtdShZKDGFW65w13AQmc99InddGRwLTi0_y_FJ8uCqvfgn1hXfCBnrgoeOOC1MLo_Mmt7wSPrjGeOmskI7DpwoTcPaF3HEzlfwHFaxC4xOZWh73BfrTGKxPLPK5sHq2DEW2_ptz8s17kr85S-MadHaP3E3GIz0ZKn2f3PLtA3L7IrnHH5LvpxN3N-0CBduObq-RzxvVF1N0v1tuNNWto3ZgxaWdSRSyX0F4vwZU6utvNPltaIxFRLvtar-heJ7RHw2FVzE67s7TftN9geQhdYppSPF4l7ZoD6_pdooRRlct_YgM0Ru_fEs1jX3D-ngbDBsWuW4fkcuz08_vz1kK08As7DV2zIa8ssE5xy0Xgi9cAbBYwJrHrW98btFs1LJsALMyCB60rCopNIxQ7Steev6YHLRd658QqivXCAcwAQiJIlTGlI12PARhLNf5IiPFOGrKJg5zDKWxVnEvU0s1jLSCkVZxpFWdkTdTme3A4PFX6XcIhkkS2bdjAmBSJUyqf2EyI68RSgrnCKie1empAzQS2bbUSVWh-6vkMiOHM0nQbTvPHsGo0tzSK6wy2BgFLzLycsrGknhfrvXdHmXw-iHaHhmpZyCetWye066WkV8cTwkaMP0ycjTi_eff_9x1T_9H1z0jdxaopvG15yE5AA3wz8Hs25kXUcN_AB0aWdE priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection (ProQuest) dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4ikCBRkJiQO1mqwdJ-GCCmpVgcqJSnuzHD_YFbtJ2Owi8f_4Ycw43lSholc_kjjzzXjssb8h5M3MpKnVuWQ-xxRmpU5ZxWvPZOoqqdOy1oHA9OKrPL8Un-f5PG649fFY5d4mBkNtW4N75McYEAPLmvHsQ_eTYdYojK7GFBq3yZ0MPBFM3VDMxwUXJp7n-4sypTzuM3wIg1mKBVYXVk4mo8DZf90yXz8t-U_INMxEZw_I_ehC0pNB5g_JLdc8IncvYpD8MflzOjJ409ZT8PBot0FWb1RiLNH9drHWVDeWmoEbl7Z1JJL9BY13Kxis3vymMXpDQ0Yi2nbL3ZrirkZ_NHRehhy5W0f7dfsDiofSMbMhxU1e2qBXvKLdmCmMLhv6BXmi127xnmoa_g3rw5kwHFhgvH1CLs9Ov306ZzFZAzOw4tgy49PCeGstN1wIPrMZgGMGMx83rnKpQedRy7wC5EovuNeyKKTQIKHSFTx3_Ck5aNrGPSNUF7YSFsACQBKZL-o6r7Tl3ovacJ3OEpLtpaZMZDLHhBorFVY0pVSDpBVIWgVJqzIh78Y-3cDjcWPrjwiGsSVycIeCdvNdRZVWWV2KWqdVanghnLdV7aQ1QloOIM9qn5C3CCWFlgI-z-h44QEGiZxb6qQoMAiWc5mQw0lL0HAzrd6DUUUL06srfUjI67Eae-Kpuca1O2yDhxDRA0lIOQHxZGTTmma5CCzjuFdQgQOYkKM93q_e_v9f9_zmj31B7s1QAcNtzkNyANh2L8Gt29avgu7-Bar7UBs priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9QwEA96gvgifmL1lAiCD14w3aRp69u53HEo55MH9xbyyS7utst1V_D_8w9zJu1W66ngazKhTec3mWkm-Q0hr2aOc28KxWKBJcwqw1ktbGSKh1oZXlmTCEzPP6mzC_nhsrgcaHLwLsyv-fu8Um-7HDNhDDwLS0wsrLpJbhWw8CKa52o-ZgxK8Dv7SzF_HDdxPImf__oqfP1k5G_p0eR1Tu-Ru0O4SI97_d4nN0LzgNw-HxLiD8n3k5Gtm7aRQjRHN1fI4I0Giy2m2y7WhprGU9fz4NLWDqSxX0F4twIcmqtvdMjU0FR9iLab5W5NcQejO-oHL1M93G2g3br9As1961jFkOKGLm0wAl7RzVgVjC4b-hE5oddh8Y4amr4N69L5L5xYYrd9RC5OTz7Pz9hQmIE5-LvYMhd56aL3XjghpZj5HIAwAy8nXKgDdxgoGlXUgFIVpYhGlaWSBjRUhVIUQTwmB03bhCeEmtLX0gMwADQyj6W1RW28iFFaJwyfZSTfa027gbUci2esdPp7qZTuNa1B0zppWlcZeTOO2fScHf-Ufo9gGCWRbzs1AAz1YL46t5W0htfciVKG6GsblHdSeQGAzm3MyGuEksZVAV7PmeFyA0wS-bX0cVliwqsQKiOHE0mwZjft3oNRD6tJp_GVIarIRZ6Rl2M3jsQTck1odyiDBw4x2shINQHxZGbTnma5SIziuC9QQ7CXkaM93n8-_e-f7un_iT8jd2ZokOkm5yE5AKyH5xDSbe2LZMs_ANL1SQo priority: 102 providerName: Springer Nature |
Title | Evaluation of the prevalence of asthma and chronic obstructive pulmonary disease among opium users, and cigarette smokers and comparison with normal population in Kharameh: a cross-sectional study |
URI | https://link.springer.com/article/10.1186/s12890-023-02734-8 https://www.proquest.com/docview/2890067131 https://www.proquest.com/docview/2885541284 https://pubmed.ncbi.nlm.nih.gov/PMC10619218 https://doaj.org/article/1b84ba090c374efd9be6dc46d36a01bf |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ti9QwEA73AuIX8RWr5xJB8INXbZs0aQWR22WPQ7lDDhcOv4Q0Td3F3Xbd7or3__xhzqTtHvVOwS8Lm0x2m-SZZpKZPEPIi8gEQa5j4RcxpjBLdOCnLCt8EdhU6CDJtCMwPT0TJxP-4SK-2CFduqN2AOsbt3aYT2qymr_--f3yPSj8O6fwiXhTh-gt82H18R1bi5_skn3nL8JQPn7lVZCJY6UM4YXsR1yI7hLNjb_RW6gcn__1t_b1SMo_3KlulTq-S-605iU9avBwj-zY8j65ddo60B-QX-MtuzetCgrWH12ukPEbFRxLdL2eLjTVZU5Nw5tLq6wlmf0Bwps54FavLmnr2aEuWxGtlrPNguKJR33YNJ65_LlrS-tF9Q2Km9Jt1kOKB8C0RIt5TpfbLGJ0VtKPyCG9sNO3VFM3Nn7t4sWwY44N9yGZHI8_j078NpGDb2A3svZNEUhT5HnODOOcRXkIwIlgVWTGpjYwaFhqEaeAalFwVmghpeAaZiuxksWWPSJ7ZVXax4Rqmac8ByAByHhYyCyLU52zouCZYTqIPBJ2s6ZMy3KOyTbmyu12EqGamVYw08rNtEo88mrbZtlwfPxTeohg2EoiP7crqFZfVavuKswSnukgDQyT3BZ5mlmRGy5yBgoQZoVHXiKUFOIaHs_o9jIEdBL5uNSRlOggi5nwyEFPErTf9Ks7MKpOeRQ-MlghIQs98nxbjS0xoq601QZlMEARrROPJD0Q93rWrylnU8dAjucIKRiHHjns8H71738fuif_NdBPye0I9dFd_DwgewB1-wwswHU2ILvyQg7I_nB89ukcvo3EaOBOUwZO4eHzfPjlNwybXmE |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJwEviE8RGGAkEA8sWhInToI0oQ06bXStENqkvRnHdmhFm5SmBe2f44k_jDvnYyoTe9urfU5i3_l88dm_HyGvAuV5WkbczSOkMEuk56Ysy13umZRLL8mkBTAdjvjhafjpLDrbIL_buzB4rLL1idZR61LhHvkOJsTAs_rMfz__4SJrFGZXWwoN2VAr6F0LMdZc7BiY81_wC1ftHn0Efb8OgoP-yYdDt2EZcBWEyktX5V6scq01UywMWaB96FUALpspkxpPYdQjeZTCkPM8ZLnkccxDCctcYmIWGQbPvUE2Q9xA6ZHN_f7o85cujxGDWHtVJ-E7lY_dcGGddC2ujJusLYeWNeDy2nD5vOY_SVu7Fh7cJXeaIJbu1VZ3j2yY4j65OWzS9A_In36HIU7LnEKMSecLxBVHN4IlslqOZ5LKQlNVo_PSMmugbH-C8GoKwy0X57TJH1HLiUTL-WQ1o7ivUm3XjSeWpXdpaDUrv0NxXdpxK1LcZqYFxuVTOu-4yuikoANEqp6Z8TsqqR0bt7Kn0rBjFnP3ITm9FkU-Ir2iLMxjQmWs01CDuYIph34eZ1mUSs3yPMwUk17gEL_VmlANljpSekyF_adKuKg1LUDTwmpaJA5527WZ10giV0rvozF0kogCbgvKxTfROBXhZ0mYSS_1FItDk-s0M1yrkGsG08zPcoe8QVMS6Kvg85RsrlxAJxH1S-zFMabhIsYdsrUmCT5GrVe3xigaH1eJixnpkJddNbbEc3uFKVcog8cgMQZySLJmxGs9W68pJmOLc467FSmEoA7Zbu394u3_H7onV3_sC3Lr8GR4LI6PRoOn5HaAk9HeLd0iPbBz8wyCzGX2vJnJlHy9bufxF5vllCs |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELdgkyZeEJ8iMMBISDywaEmdODFvBTaNjk1IMGlvlj9pRZtUTYvE_8cfxp2TBsIAiVf7rMS-39lnn_07Qp6PTJJYlfPY55jCrFRJLJj2MU-c4CoptQoEpmfn_OQim1zml7-84g-33bchyfZNA7I0VevDpfWtiZf8sEkxPhbDehMHfpa4vE52y1wI2H7tjseTj5M-klDAerR9LPPHloMFKfD2X52dr96Y_C1sGlaj41vkZudG0nGr99vkmqvukL2zLlB-l3w_6lm8ae0peHl0uUJmbzRkLFHNerpQVFWWmpYfl9a6I5P9CsKbOeBTrb7RLoJDQ1YiWi9nmwXFk43moG08C3ly1442i_oLFLelfXZDige9tELPeE6XfbYwOqvoKXJFL9z0FVU0jE3chHth2LHAenuPXBwffXpzEncJG2IDu451bHxSGG-tZYZlGRvZFAAygtWPGSdcYtCBVDwXgF7uM-YVLwqeKdBQ6QqWO3af7FR15R4QqgorMguAATBlqS-0zoWyzPtMG6aSUUTSrdak6djMManGXIZdTcllq2kJmpZB07KMyMu-zbLl8vin9GsEQy-JPNyhoF59lp1Zy1SXmVaJSAwrMuet0I5bk3HLAOip9hF5gVCSOFvA7xnVPXqATiLvlhwXBQbCcsYjsj-QBCs3w-otGGU3yzQSfxm8jZSlEXnWV2NLvDlXuXqDMngREb2QiJQDEA96NqypZtPANI7nBQKcwIgcbPH-8-t_H7qH_yf-lOx9eHss3787P31EbozQNsNjz32yA7B3j8HrW-snnWH_AJXNVbc |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluation+of+the+prevalence+of+asthma+and+chronic+obstructive+pulmonary+disease+among+opium+users%2C+and+cigarette+smokers+and+comparison+with+normal+population+in+Kharameh%3A+a+cross-sectional+study&rft.jtitle=BMC+pulmonary+medicine&rft.au=Raeisy%2C+Laleh&rft.au=Masoompour%2C+Seyed+Masoom&rft.au=Rezaianzadeh%2C+Abbas&rft.date=2023-11-01&rft.issn=1471-2466&rft.eissn=1471-2466&rft.volume=23&rft.issue=1&rft_id=info:doi/10.1186%2Fs12890-023-02734-8&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12890_023_02734_8 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2466&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2466&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2466&client=summon |